297 related articles for article (PubMed ID: 32141397)
1. Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of
Bhowmik D; Jagadeesan R; Rai P; Nandi R; Gugan K; Kumar D
J Biomol Struct Dyn; 2021 Mar; 39(5):1838-1852. PubMed ID: 32141397
[No Abstract] [Full Text] [Related]
2. In-silico studies on Myo inositol-1-phosphate synthase of
Sinha M; Jagadeesan R; Kumar N; Saha S; Kothandan G; Kumar D
J Biomol Struct Dyn; 2022 May; 40(8):3371-3384. PubMed ID: 33200690
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing based novel anti-leishmanial drug screening using
Rai P; Arya H; Saha S; Kumar D; Bhatt TK
J Biomol Struct Dyn; 2022; 40(21):10812-10820. PubMed ID: 36529188
[TBL] [Abstract][Full Text] [Related]
4. Screening of Novel Inhibitors Against Leishmania donovani Calcium ion Channel to Fight Leishmaniasis.
Kashif M; Manna PP; Akhter Y; Alaidarous M; Rub A
Infect Disord Drug Targets; 2017; 17(2):120-129. PubMed ID: 28034363
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches.
Nath M; Bhowmik D; Saha S; Nandi R; Kumar D
Sci Rep; 2024 Feb; 14(1):3246. PubMed ID: 38332162
[TBL] [Abstract][Full Text] [Related]
6. Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
Pandey RK; Sharma D; Bhatt TK; Sundar S; Prajapati VK
J Biomol Struct Dyn; 2015; 33(12):2541-53. PubMed ID: 26305585
[TBL] [Abstract][Full Text] [Related]
7. In-silico screening and validation of high-affinity tetra-peptide inhibitor of Leishmania donovani O-acetyl serine sulfhydrylase (OASS).
Kant V; Vijayakumar S; Sahoo GC; Ali V; Singh K; Chaudhery SS; Das P
J Biomol Struct Dyn; 2019 Feb; 37(2):481-492. PubMed ID: 29415627
[TBL] [Abstract][Full Text] [Related]
8. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
[TBL] [Abstract][Full Text] [Related]
10. Investigation into in silico and in vitro approaches for inhibitors targeting MCM10 in Leishmania donovani: a comprehensive study.
Saha S; Sharma A; Bhowmik D; Kumar D
Mol Divers; 2024 May; ():. PubMed ID: 38722455
[TBL] [Abstract][Full Text] [Related]
11. Dual-target drugs against Leishmania donovani for potential novel therapeutics.
Bora K; Sarma M; Kanaujia SP; Dubey VK
Sci Rep; 2023 Oct; 13(1):18363. PubMed ID: 37884555
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and structure-based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani.
Singh S; Vijaya Prabhu S; Suryanarayanan V; Bhardwaj R; Singh SK; Dubey VK
J Biomol Struct Dyn; 2016 Nov; 34(11):2367-86. PubMed ID: 26551589
[TBL] [Abstract][Full Text] [Related]
13. Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis.
Sheikh SY; Ansari WA; Hassan F; Faruqui T; Khan MF; Akhter Y; Khan AR; Siddiqui MA; Al-Khedhairy AA; Nasibullah M
J Mol Recognit; 2023 Jul; 36(7):e3021. PubMed ID: 37092713
[TBL] [Abstract][Full Text] [Related]
14. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
[TBL] [Abstract][Full Text] [Related]
15. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.
Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK
Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
17. Identification of Selective Inhibitors of
Sharma VK; Bharatam PV
J Comput Biol; 2021 Jan; 28(1):43-59. PubMed ID: 32207987
[TBL] [Abstract][Full Text] [Related]
18. N-acetylglucosamine-phosphatidylinositol de-N-acetylase as a novel target for probing potential inhibitor against
Kumar M; Tripathi MK; Gupta D; Kumar S; Biswas NR; Ethayathulla AS; Kaur P
J Biomol Struct Dyn; 2023 Mar; 41(5):1904-1918. PubMed ID: 35014594
[No Abstract] [Full Text] [Related]
19. Computational evaluation of phytochemicals targeting DNA topoisomerase I in
Arya PK; Mandal P; Barik K; Singh DV; Kumar A
J Biomol Struct Dyn; 2023 Sep; ():1-14. PubMed ID: 37697722
[TBL] [Abstract][Full Text] [Related]
20. Potential inhibitors for FKBP51: an
Barge S; Jade D; Ayyamperumal S; Manna P; Borah J; Nanjan CMJ; Nanjan MJ; Talukdar NC
J Biomol Struct Dyn; 2022; 40(24):13799-13811. PubMed ID: 34709133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
